SEC Form 4 · accession 0001487371-18-000124
GenMark Diagnostics, Inc. · GNMK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James Fox
Director
Period of report
May 24, 2018
Accepted (ET)
May 29, 2018 · 6:59 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001487371
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 24, 2018 | A | 24,625 | $0.00 | A | 135,707 | D | |
| Common StockF2 | holding | — | — | — | 72,085 | I | Penashe Holdings Propriety Limited |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The amount reported reflects restricted stock units granted to the Reporting Person pursuant to the Issuer's 2010 Equity Incentive Plan, which vest in full on the first anniversary of the grant date.
- F2Dr. Fox is an executive director of Penashe Holdings Propriety Limited and may be deemed to have beneficial ownership of these securities, to the extent of any indirect pecuniary interest in his distributive shares therein.